A detailed history of Nbc Securities, Inc. transactions in Cassava Sciences Inc stock. As of the latest transaction made, Nbc Securities, Inc. holds 9,650 shares of SAVA stock, worth $259,681. This represents 0.02% of its overall portfolio holdings.

Number of Shares
9,650
Previous 7,650 26.14%
Holding current value
$259,681
Previous $94,000 201.06%
% of portfolio
0.02%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$9.57 - $35.08 $19,140 - $70,160
2,000 Added 26.14%
9,650 $283,000
Q1 2024

Apr 05, 2024

BUY
$18.44 - $26.41 $11,986 - $17,166
650 Added 9.29%
7,650 $155,000
Q4 2023

Feb 07, 2024

BUY
$12.64 - $30.11 $37,920 - $90,330
3,000 Added 75.0%
7,000 $157,000
Q3 2023

Nov 03, 2023

BUY
$16.64 - $25.32 $66,560 - $101,280
4,000 New
4,000 $66,000

Others Institutions Holding SAVA

About CASSAVA SCIENCES INC


  • Ticker SAVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,097,900
  • Market Cap $1.08B
  • Description
  • Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...
More about SAVA
Track This Portfolio

Track Nbc Securities, Inc. Portfolio

Follow Nbc Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nbc Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nbc Securities, Inc. with notifications on news.